- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Ipilimumab – July 2011
Ipilimumab, concentrate solution for I.V. infusion, 50 mg in 10 mL, 200 mg in 40 mL, Yervoy® - July 2011
Last updated
11 November 2011